Primary Care Diabetes
Volume 4, Issue 2 , Pages 69-72 , July 2010

The perfect diabetes review

  • Paul Grant

      Affiliations

    • Corresponding Author InformationTel.: +44 01273 696955; fax: +44 07775 837334.

Received 13 August 2009 ,Revised 3 February 2010 ,Accepted 8 February 2010.

References 

  1. Grant P, Lipscomb D. How often do we ask about erectile dysfunction in the diabetes review clinic?. Acta Diabetol. 2008;(December):
  2. Golay A, Lagger G, Chambouleyron M, Carrard I, Lasserre-Moutet A. Therapeutic education of diabetic patients. Diabetes Metab. Res. Rev. 2008;24(March–April (3)):192–196
  3. Channon SJ, Huws-Thomas MV, Rollnick S, Hood K, Cannings-John RL, Rogers C, et al. A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care. 2007;30(June (6)):1390–1395
  4. Sørensen JB, Kragstrup J, Skovgaard T, Puggaard L. Exercise on prescription: a randomized study on the effect of counseling vs. counseling and supervised exercise. Scand. J. Med. Sci. Sports. 2008;18(June (3)):288–297
  5. Grant P, McIntyre HF. Dipeptidyl peptidase-IV inhibitors: fixing type 2 diabetes?. Br. J. Hosp. Med. (Lond.). 2007;68(November (11)):599–602
  6. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann. Surg. 2002;236(November (5)):554–559Review
  7. Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. J. Med. Screen. 2008;15(1):1–4
  8. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006;49(August (8)):1761–1769
  9. Ong HT, Cheah JS. Choice of antihypertensive drug in the diabetic patient. Med. Gen. Med. 2005;7(May (2)):74;Review
  10. Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, et al. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrol. Dial. Transplant. 2008;23(April (4)):1216–1223
  11. Grundy SM, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(July):227–239
  12. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin. Neurol. Neurosurg. 2006;108(July (5)):477–481
  13. Cleveringa FG, Meulenberg MG, Gorter KJ, van den Donk M, Rutten GE. The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age. J. Diabetes Complications. 2008;(February):
  14. National Institute for Health and Clinical Excellence, CG15 Type 1 diabetes in adults: full guideline, references and appendices, 2004.
  15. The National Service Framework for Diabetes 2001 and 2006. http://www.dh.gov.uk/en/Healthcare/NationalServiceFrameworks/Diabetes/index.htm.
  16. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18:754–760
  17. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV. Diabetes guidelines: easier to preach than to practise?. Med. J. Aust. 2006;185(September (6)):305–309
  18. Glasgow RE, Peeples M, Skovlund SE. Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures. Diabetes Care. 2008;31(May (5)):1046–1050
  19. Barth JH, Marshall SM, Watson ID. Consensus meeting on reporting glycated haemoglobin (HbA1c) and estimated average glucose (eAG) in the UK: report to the National Director for Diabetes, Department of Health. Diabet. Med. 2008;25(April (4)):381–382

PII: S1751-9918(10)00008-2

doi: 10.1016/j.pcd.2010.02.001

Primary Care Diabetes
Volume 4, Issue 2 , Pages 69-72 , July 2010

Article Tools